| XLS |
|
|
|
|
|
€ million |
Q2 – 2014 |
Q2 – 2013 |
Jan.–June 2014 |
Jan.–June 2013 |
Profit after tax |
306.0 |
316.1 |
633.4 |
585.1 |
Items of other comprehensive income that will not be reclassified to profit or loss in subsequent periods: |
|
|
|
|
Remeasurement of the net defined benefit liability |
|
|
|
|
Changes in remeasurement |
–80.6 |
44.2 |
–245.3 |
–43.6 |
Deferred taxes |
15.0 |
–7.9 |
45.2 |
6.8 |
Changes recognized in equity |
–65.6 |
36.3 |
–200.1 |
–36.8 |
|
–65.6 |
36.3 |
–200.1 |
–36.8 |
Items of other comprehensive income that may be reclassified to profit or loss in subsequent periods: |
|
|
|
|
Available-for-sale financial assets |
|
|
|
|
Fair value adjustments |
–0.5 |
0.1 |
–1.1 |
0.8 |
Reclassification to profit or loss |
– |
– |
1.7 |
– |
Deferred taxes |
|
–0.1 |
–0.1 |
–0.5 |
Changes recognized in equity |
–0.4 |
– |
0.5 |
0.3 |
Derivative financial instruments |
|
|
|
|
Fair value adjustments |
–29.5 |
65.1 |
–52.5 |
43.7 |
Reclassification to profit or loss |
–12.2 |
–1.8 |
–26.2 |
–4.9 |
Reclassification to assets |
– |
– |
– |
– |
Deferred taxes |
10.2 |
–14.7 |
19.0 |
–7.2 |
Changes recognized in equity |
–31.5 |
48.6 |
–59.7 |
31.6 |
Exchange differences on translating foreign operations |
|
|
|
|
Changes taken directly to equity |
78.4 |
–98.3 |
89.0 |
–77.3 |
Reclassification to profit or loss |
– |
–7.6 |
– |
–7.6 |
Changes recognized in equity |
78.4 |
–105.9 |
89.0 |
–84.9 |
|
46.5 |
–57.3 |
29.8 |
–53.1 |
Other comprehensive income |
–19.1 |
–21.0 |
–170.3 |
–89.9 |
Comprehensive income |
286.9 |
295.1 |
463.1 |
495.2 |
of which attributable to Merck KGaA shareholders |
285.1 |
299.7 |
456.2 |
495.0 |
of which attributable to non-controlling interests |
1.8 |
–4.6 |
6.9 |
0.2 |